1. Klein BE, Klein R, Lee KE, Gangnon RE. Incidence of age-related cataract over a 15-year interval the Beaver Dam Eye Study. Ophthalmology. 2008; 115:477–482.
2. Vashist P, Talwar B, Gogoi M, Maraini G, Camparini M, Ravindran RD, et al. Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology. 2011; 118:272–278.
Article
3. Xu L, Cui T, Zhang S, Sun B, Zheng Y, Hu A, et al. Prevalence and risk factors of lens opacities in urban and rural Chinese in Beijing. Ophthalmology. 2006; 113:747–755.
Article
4. Seah SK, Wong TY, Foster PJ, Ng TP, Johnson GJ. Prevalence of lens opacity in Chinese residents of Singapore: the tanjong pagar survey. Ophthalmology. 2002; 109:2058–2064.
Article
5. Congdon N, Vingerling JR, Klein BE, West S, Friedman DS, Kempen J, et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol. 2004; 122:487–494.
Article
6. Hiller R, Sperduto RD, Ederer F. Epidemiologic associations with nuclear, cortical, and posterior subcapsular cataracts. Am J Epidemiol. 1986; 124:916–925.
Article
7. Kanthan GL, Wang JJ, Rochtchina E, Tan AG, Lee A, Chia EM, et al. Ten-year incidence of age-related cataract and cataract surgery in an older Australian population. The Blue Mountains Eye Study. Ophthalmology. 2008; 115:808–814.
Article
8. Rim TH, Kim MH, Kim WC, Kim TI, Kim EK. Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination survey 2008-2010. BMC Ophthalmol. 2014; 14:4.
Article
9. McElroy JA, Klein BE, Lee KE, Howard KP, Klein R. Place-based exposure and cataract risk in the Beaver Dam cohort. J Environ Health. 2014; 76:34–40.
10. Leske MC, Wu SY, Hennis A, Connell AM, Hyman L, Schachat A. Diabetes, hypertension, and central obesity as cataract risk factors in a black population. The Barbados Eye Study. Ophthalmology. 1999; 106:35–41.
11. Mukesh BN, Le A, Dimitrov PN, Ahmed S, Taylor HR, McCarty CA. Development of cataract and associated risk factors: the Visual Impairment Project. Arch Ophthalmol. 2006; 124:79–85.
12. Berendschot TT, Broekmans WM, Klöpping-Ketelaars IA, Kardinaal AF, Van Poppel G, Van Norren D. Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract. Arch Ophthalmol. 2002; 120:1732–1737.
Article
13. Leske MC, Chylack LT Jr, Wu SY. The Lens Opacities Case-Control Study. Risk factors for cataract. Arch Ophthalmol. 1991; 109:244–251.
14. Feder J. Too big to fail: the enactment of health care reform. J Health Polit Policy Law. 2011; 36:413–416.
Article
15. Nagatomo F, Roy RR, Takahashi H, Edgerton VR, Ishihara A. Effect of exposure to hyperbaric oxygen on diabetes-induced cataracts in mice. J Diabetes. 2011; 3:301–308.
Article
16. Chen KJ, Pan WH, Huang CJ, Lin BF. Association between folate status, diabetes, antihypertensive medication and age-related cataracts in elderly Taiwanese. J Nutr Health Aging. 2011; 15:304–310.
Article
17. Kim SI, Kim SJ. Prevalence and risk factors for cataracts in persons with type 2 diabetes mellitus. Korean J Ophthalmol. 2006; 20:201–204.
Article
18. Nemet AY, Hanhart J, Kaiserman I, Vinker S. Are cataracts associated with osteoporosis? Clin Ophthalmol. 2013; 7:2079–2084.
Article
19. Klein BE, Klein R, Lee KE. Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver Dam Eye Study. Am J Ophthalmol. 1998; 126:782–790.
Article
20. Naeem SS, Siddiqui EU, Kazi AN, Khan S, Abdullah FE, Adhi I. Prevalence of hepatitis 'B' and hepatitis 'C' among preoperative cataract patients in Karachi. BMC Res Notes. 2012; 5:492.
Article
21. Christensen JD. Frequency of cataract in atopic dermatitis. Acta Derm Venereol. 1981; 61:76–77.
22. Pham TQ, Wang JJ, Rochtchina E, Maloof A, Mitchell P. Systemic and ocular comorbidity of cataract surgical patients in a western Sydney public hospital. Clin Experiment Ophthalmol. 2004; 32:383–387.
Article
23. LaForce C, Journeay GE, Miller SD, Silvey MJ, Wu W, Lee LA, et al. Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study. Ann Allergy Asthma Immunol. 2013; 111:45–50.
Article
24. Emin O, Fatih M, Mustafa O, Nedim S, Osman C. Evaluation impact of long-term usage of inhaled fluticasone propionate on ocular functions in children with asthma. Steroids. 2011; 76:548–552.
Article
25. Wang S, Xu L, Jonas JB, You QS, Wang YX, Yang H. Dyslipidemia and eye diseases in the adult Chinese population: the Beijing eye study. PLoS One. 2012; 7:e26871.
Article
26. Rim TH, Park SY, Kim TI. Epidemiological Survey Regarding Cataract Awareness in Korea: KNHANES IV. J Korean Ophthalmol Soc. 2013; 54:72–77.
Article
27. McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: allostasis and allostatic load. Metabolism. 2006; 55:10 Suppl 2. S20–S23.
Article